-
Kilburn, LB, Khuong-Quang, D-A, Nysom, K, Landi, DB, Ziegler, DS, Hernáiz Driever, P, Leary, S, Bailey, S, van der Lugt, J, Perreault, S, et al.
Clinical activity of pan-RAF inhibitor tovorafenib in the registrational pediatric low-grade glioma arm of the phase 2 FIREFLY-1 (PNOC026) study..
Journal of Clinical Oncology
41(16_suppl)
:
10004 -10004
2023
view publication
-
Jackson, ER, Duchatel, RJ, Staudt, DE, Persson, ML, Mannan, A, Yadavilli, S, Parackal, S, Game, S, Chong, WC, Jayasekara, WSN, et al.
ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma..
Cancer Res
OF1 -OF17
2023
view publication
-
Jackson, ER, Duchatel, RJ, Staudt, DE, Persson, ML, Mannan, A, Yadavilli, S, Parackal, S, Game, S, Chong, WC, Jayasekara, WSN, et al.
ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma..
Cancer Res
2023
view publication
-
Valvi, S, Dun, MD, Hansford, JR.
National brain tumour registry: a new era of research collaboration with China..
Lancet Reg Health West Pac
34:
100739
2023
view publication
-
Subasri, V, Light, N, Kanwar, N, Brzezinski, J, Luo, P, Hansford, JR, Cairney, E, Portwine, C, Elser, C, Finlay, JL, et al.
Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome..
Cancer Res Commun
3(5)
:
738 -754
2023
view publication